NASH in HIV

A Cervo, M Shengir, K Patel, G Sebastiani - Current HIV/AIDS Reports, 2020 - Springer
Abstract Purpose of Review Aging-related comorbidities, including liver disease, represent
the main drivers of morbidity and mortality in people with HIV (PWH). Nonalcoholic fatty liver …

[HTML][HTML] Loco-regional treatments for hepatocellular carcinoma in people living with HIV

C Micali, Y Russotto, G Caci, M Ceccarelli… - Infectious Disease …, 2022 - mdpi.com
Hepatocellular carcinoma (HCC) accounts for approximately 75–90% of primary liver
cancers and is the sixth most common cancer and the third leading cause of cancer-related …

Prevalence, predictors, and severity of lean nonalcoholic fatty liver disease in patients living with human immunodeficiency virus

A Cervo, J Milic, G Mazzola, F Schepis… - Clinical Infectious …, 2020 - academic.oup.com
Background The burden of nonalcoholic fatty liver disease (NAFLD) is growing in people
living with human immunodeficiency virus (HIV). NAFLD is associated with obesity; however …

Temporal trends and outcomes in liver transplantation for recipients with HIV infection in Europe and United States

I Campos-Varela, JL Dodge, M Berenguer… - …, 2020 - journals.lww.com
Background. We evaluated trends and outcomes of liver transplantation (LT) recipients
with/without HIV infection. Methods. LT recipients between 2008 and 2015 from the United …

Hepatic steatosis and nonalcoholic fatty liver disease are common and associated with cardiometabolic risk in a primary prevention cohort of people with HIV

JE Lake, J Taron, HJ Ribaudo, J Leon-Cruz, NS Utay… - AIDS, 2023 - journals.lww.com
Background: Hepatic steatosis, including nonalcoholic fatty liver disease (NAFLD), is
common among people with HIV (PWH). We present baseline steatosis prevalence and …

Splenomegaly is a marker of advanced chronic liver disease and portal hypertension in HIV infection

D Kablawi, A Alhinai, P Wong, M Deschenes… - HIV …, 2023 - Wiley Online Library
Objectives To evaluate the clinical significance of splenomegaly as a marker of underlying
liver disease in people with HIV (PWH). Methods We included consecutive PWH from a …

Material deprivation is associated with liver stiffness and liver‐related outcomes in people with HIV

C Long, F Cinque, D Kablawi, DHD Kim… - Liver …, 2024 - Wiley Online Library
Background Socioeconomic status (SES) is a driver of health disparities and chronic
diseases. People with HIV (PWH) are at risk for chronic liver diseases. We evaluated the …

Prognostic value of non‐invasive scores based on liver stiffness measurement, spleen diameter and platelets in HIV‐infected patients

A Benmassaoud, J Macias, A Delamarre… - Liver …, 2023 - Wiley Online Library
Abstract Background and Aims People living with HIV (PLWH) are at high risk for advanced
chronic liver disease and related adverse outcomes. We aimed to validate the prognostic …

Nonalcoholic fatty liver disease and the development of metabolic comorbid conditions in patients with human immunodeficiency virus infection

T Krahn, M Martel, R Sapir-Pichhadze… - The Journal of …, 2020 - academic.oup.com
Background Cardiovascular and liver disease are main causes of death in people with
human immunodeficiency virus (HIV)(PWH). In HIV-uninfected patients, nonalcoholic fatty …

Prediction of esophageal varices by liver stiffness and platelets in persons with human immunodeficiency virus infection and compensated advanced chronic liver …

N Merchante, C Saroli Palumbo… - Clinical Infectious …, 2020 - academic.oup.com
Background People living with human immunodeficiency virus (PLWH) are at increased risk
of cirrhosis and esophageal varices. Baveno VI criteria, based on liver stiffness …